RCP Therapeutics Ltd acquires the IP and assets of Telemolecular Corporation

New operational headquarters situated in London, UK

07-Nov-2008 - United Kingdom

RCP Therapeutics, a biopharmaceuticals company specialising in converging nanotechnology and regenerative medical markets, announced that it has exclusively licensed technologies from Telemolecular Corporation (USA). The Company’s portfolio of intellectual property is strategically focused on the regenerative, preventative and curative elements of age related disease states.

RCP Therapeutics has identified a series of product candidates and has pilot launched its lead product candidate, Bimene, a novel cosmeceutical topical product, utilising its nano particle delivery platform acquired via licenses from universities and US based research institutions.

New management, appointed to run Telomolecular Corporation in May 2008, set in motion a business strategy culminating in the formation of RCP Therapeutics. Operationally, the Company will retain its research laboratory in Sacramento, securing the facilities status as RCP Therapeutics’ primary research and development site. Furthermore, the Company’s plans to expand the Californian operation and increase the number of scientists and staff employed at the site. Commercialisation of RCP Therapeutics’ cosmeceutical products in the US will be co-ordinated from the same location.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures
View topic world
Topic world biopharmaceutical manufacturing

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures